Cargando…

Dynamics of the lung microbiome in intensive care patients with chronic obstructive pulmonary disease and community-acquired pneumonia

Little is known about the composition and clinical implications of lung microbiome in patients with chronic obstructive pulmonary disease (COPD) and community-acquired pneumonia requiring invasive mechanical ventilation and intensive care unit admission. Therefore, this study aimed to explore the lo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Wei-Chang, Wu, Ming-Feng, Huang, Chen-Cheng, Liu, Sin-Yin, Chen, Hui-Chen, Chen, Yih-Yuan, Hsu, Jeng-Yuan, Huang, Chieh-Chen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338533/ https://www.ncbi.nlm.nih.gov/pubmed/32632240 http://dx.doi.org/10.1038/s41598-020-68100-4

Ejemplares similares

Clinical features, bacteriology of endotracheal aspirates and treatment outcomes of patients with chronic obstructive pulmonary disease and community-acquired pneumonia in an intensive care unit in Taiwan with an emphasis on eosinophilia versus non-eosinophilia: a retrospective case–control study
por: Huang, Wei-Chang, et al.
Publicado: (2018)

Clinical Features and Antimicrobial Susceptibility of Pseudomonas aeruginosa and Acinetobacter baumannii Complex Isolates in Intensive Care Patients with Chronic Obstructive Pulmonary Disease and Community-Acquired Pneumonia in Taiwan
por: Chang, Ko-Yun, et al.
Publicado: (2021)

Bacteremic community-acquired pneumonia due to Klebsiella pneumoniae: Clinical and microbiological characteristics in Taiwan, 2001-2008
por: Lin, Yi-Tsung, et al.
Publicado: (2010)

Current Status of Community-Acquired Pneumonia in Patients with Chronic Obstructive Pulmonary Disease
por: Liu, De-Shun, et al.
Publicado: (2018)

Macrolide-Resistant Mycoplasma pneumoniae Infections in Pediatric Community-Acquired Pneumonia
por: Chen, Yu-Chin, et al.
Publicado: (2020)

A prediction model for hospital mortality in patients with severe community-acquired pneumonia and chronic obstructive pulmonary disease
por: Huang, Dong, et al.
Publicado: (2022)

Circulating sphingosine-1-phosphate as a prognostic biomarker for community-acquired pneumonia
por: Hsu, Shih-Chang, et al.
Publicado: (2019)

Clinical Features, Etiology and Outcomes of Community-Acquired Pneumonia in Patients with Chronic Obstructive Pulmonary Disease
por: Gómez-Junyent, Joan, et al.
Publicado: (2014)

Early readmission and mortality in acute exacerbation of chronic obstructive pulmonary disease with community-acquired pneumonia
por: Shin, Beomsu, et al.
Publicado: (2018)

Impact of acute kidney injury on in-hospital outcomes in Chinese patients with community acquired pneumonia
por: Chen, Dawei, et al.
Publicado: (2021)

Clinical muscle mass-related biomarkers that predict mortality in older patients with community-acquired pneumonia
por: Huang, Sha, et al.
Publicado: (2022)

Severe community-acquired pneumonia in the intensive care unit
por: Costa, C, et al.
Publicado: (2005)

Comparison of clinical characteristics and outcomes between aspiration pneumonia and community-acquired pneumonia in patients with chronic obstructive pulmonary disease
por: Yamauchi, Yasuhiro, et al.
Publicado: (2015)

Dynamic nomogram for predicting acute kidney injury in patients with community-acquired pneumonia
por: Chen, Dawei, et al.
Publicado: (2023)

Advances in severe community-acquired pneumonia
por: Wang, Jian, et al.
Publicado: (2019)

Association between Obstructive Sleep Apnea and Community-Acquired Pneumonia
por: Chiner, Eusebi, et al.
Publicado: (2016)

Plasma kallistatin levels in patients with severe community-acquired pneumonia
por: Lin, Wei-Chieh, et al.
Publicado: (2013)

The association between airflow limitation and blood eosinophil levels with treatment outcomes in patients with chronic obstructive pulmonary disease and prolonged mechanical ventilation
por: Huang, Wei-Chang, et al.
Publicado: (2019)

Clinical characteristics, diagnosis, outcomes and lung microbiome analysis of invasive pulmonary aspergillosis in the community-acquired pneumonia patients
por: Ao, Zhi, et al.
Publicado: (2023)

Effect of corticosteroids on mortality in patients with community-acquired pneumonia
por: Chen, Shangzhong, et al.
Publicado: (2023)

Community-acquired pneumonia and survival of critically ill acute exacerbation of COPD patients in respiratory intensive care units
por: Lu, Zhiwei, et al.
Publicado: (2016)

Application of nested multiplex polymerase chain reaction respiratory and pneumonia panels in children with severe community‐acquired pneumonia
por: Yen, Ting‐Yu, et al.
Publicado: (2022)

Inhaled Corticosteroids and the Pneumonia Risk in Patients With Chronic Obstructive Pulmonary Disease: A Meta-analysis of Randomized Controlled Trials
por: Chen, Hong, et al.
Publicado: (2021)

The role of transthoracic ultrasonography in predicting the outcome of community-acquired pneumonia in hospitalized children
por: Chen, I-Chen, et al.
Publicado: (2017)

Characteristics and etiology of hospitalized pediatric community-acquired pneumonia in Taiwan
por: Chi, Hsin, et al.
Publicado: (2020)

1336. Impact of Procalcitonin-Guided Antibiotic Management in Chronic Obstructive Pulmonary Disease Exacerbation and Community-Acquired Pneumonia
por: Triner, Molly, et al.
Publicado: (2019)

Efficacy and Safety of Nemonoxacin in Outpatients with Community-Acquired Pneumonia
por: Zhao, Bo, et al.
Publicado: (2020)

Comparison of respiratory pathogens in children with community-acquired pneumonia before and during the COVID-19 pandemic
por: Tang, Mingyu, et al.
Publicado: (2023)

Age-specific risk factors of severe pneumonia among pediatric patients hospitalized with community-acquired pneumonia
por: Chen, Lumin, et al.
Publicado: (2021)

Genotypic and phenotypic characteristics of Streptococcus pneumoniae from community-acquired pneumonia patients and healthy asymptomatic participants in Sichuan province, China
por: Peng, Shihui, et al.
Publicado: (2021)

Sphingosine-1-phosphate and CRP as potential combination biomarkers in discrimination of COPD with community-acquired pneumonia and acute exacerbation of COPD
por: Hsu, Chin-Wang, et al.
Publicado: (2022)

Sphingosine-1-phosphate as an indicator for deciding the use of adjuvant corticosteroids therapy in community-acquired pneumonia (sphingosine-1-phosphate and pneumonia trial): Study protocol for a randomized, placebo-controlled trial
por: Hsu, Shih-Chang, et al.
Publicado: (2019)

Association of admission blood glucose level and clinical outcomes in elderly community‐acquired pneumonia patients with or without diabetes
por: Zeng, Weijian, et al.
Publicado: (2022)

The drug use to treat community-acquired pneumonia in children: A cross-sectional study in China
por: Mi, Xue, et al.
Publicado: (2018)

Isolated pulmonary valve endocarditis masquerading as community-acquired pneumonia
por: Nazir, Salik, et al.
Publicado: (2016)

COMMUNITY-ACQUIRED PNEUMONIA
por: Haas, Andrew R., et al.
Publicado: (2009)

Community-acquired pneumonia
por: File, Thomas M
Publicado: (2003)

Community-Acquired Pneumonia
por: Sialer, Salvador, et al.
Publicado: (2014)

Community Acquired Pneumonia
por: Wunderink, Richard G., et al.
Publicado: (2016)

Community-Acquired Pneumonia
por: Boza Costagliola, María Lina
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mv2caa7668rji1rlpt0egle464